Detalles de la búsqueda
1.
TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer.
Breast Cancer Res
; 22(1): 22, 2020 02 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32070401
Resultados
1 -
1
de 1
1
Próxima >
>>